Tolvaptan (OPC41061, 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino) benzoyl]-2,3,4,5- tetrahydro-1H-1-benzazepine), OPC31260 (Mozavaptan, 5-(Dimethylamino)-1-[4-(2-methylbenzamido)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine hydrochloride), 8-Br-cAMP, and dDAVP (1-desamino-8-d-arginine vasopressin) were from Sigma Millipore (St. Louis, MO). Primary antibodies were purchased for phosphorylated cAMP response element binding protein (pCREB) (#9198S), CREB (#9197S), Ki-67 (#9449S), phosphorylated extracellular signal regulated kinase (pERK1/2) (#9101S), and ERK1/2 (#SC-94) from Cell Signaling Technology (Danvers, CA, USA); vascular endothelial growth factor (VEGF) (#SC-7269) and GAPDH (#SC-47724) from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and V2R (#V5514) from Sigma Millipore (St. Louis, MO, USA) and CD31 (#ab28364) from Abcam (Cambridge, MA, USA). Secondary antibodies were from Dako (Carpinteria, CA) and ECL reagent was from Perkin Elmer (Waltham, MA, USA).
Opc41061
Manufactured by Merck Group
OPC41061 is a laboratory equipment product manufactured by Merck Group. It is designed to facilitate scientific research and analysis. The core function of this product is to provide a reliable and precise measurement tool for researchers and laboratory professionals. No further details about the intended use or interpretation of this product are provided.
Automatically generated - may contain errors
Lab products found in correlation
Erk1 2, by Cell Signaling Technology (2 mentions)
P erk1 2, by Cell Signaling Technology (2 mentions)
Ecl reagent, by PerkinElmer (2 mentions)
8 br camp, by Merck Group (2 mentions)
Tolvaptan, by Merck Group (2 mentions)
Ddavp, by Merck Group (2 mentions)
Opc31260, by Merck Group (2 mentions)
Gapdh, by Santa Cruz Biotechnology (2 mentions)
2 protocols using opc41061
1
Vasopressin Receptor Signaling Modulators
2
Vasopressin Receptor Signaling Modulators
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Tolvaptan (OPC41061, 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino) benzoyl]-2,3,4,5- tetrahydro-1H-1-benzazepine), OPC31260 (Mozavaptan, 5-(Dimethylamino)-1-[4-(2-methylbenzamido)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine hydrochloride), 8-Br-cAMP, and dDAVP (1-desamino-8-d-arginine vasopressin) were from Sigma Millipore (St. Louis, MO). Primary antibodies were purchased for phosphorylated cAMP response element binding protein (pCREB) (#9198S), CREB (#9197S), Ki-67 (#9449S), phosphorylated extracellular signal regulated kinase (pERK1/2) (#9101S), and ERK1/2 (#SC-94) from Cell Signaling Technology (Danvers, CA, USA); vascular endothelial growth factor (VEGF) (#SC-7269) and GAPDH (#SC-47724) from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and V2R (#V5514) from Sigma Millipore (St. Louis, MO, USA) and CD31 (#ab28364) from Abcam (Cambridge, MA, USA). Secondary antibodies were from Dako (Carpinteria, CA) and ECL reagent was from Perkin Elmer (Waltham, MA, USA).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!